Senseonics (NYSE:SENS) Hits New 1-Year High – Time to Buy?

Senseonics Holdings, Inc. (NYSE:SENS) reached a new 52-week high on Thursday . The stock traded as high as $0.85 and last traded at $0.84, with a volume of 16359777 shares traded. The stock had previously closed at $0.71.

Analyst Ratings Changes

Several analysts have commented on SENS shares. HC Wainwright restated a “buy” rating and issued a $2.00 price target on shares of Senseonics in a report on Friday, November 15th. StockNews.com initiated coverage on Senseonics in a report on Thursday, December 26th. They issued a “sell” rating on the stock.

Senseonics Stock Performance

The stock’s 50-day moving average is $0.41 and its 200-day moving average is $0.40. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17. The stock has a market cap of $511.98 million, a price-to-earnings ratio of -6.63 and a beta of 0.64.

Insider Activity at Senseonics

In other news, CFO Frederick T. Sullivan purchased 124,933 shares of the company’s stock in a transaction that occurred on Thursday, December 12th. The shares were purchased at an average price of $0.38 per share, with a total value of $47,474.54. Following the purchase, the chief financial officer now directly owns 2,478,844 shares of the company’s stock, valued at approximately $941,960.72. This represents a 5.31 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Timothy T. Goodnow acquired 315,000 shares of the business’s stock in a transaction on Tuesday, December 10th. The stock was purchased at an average price of $0.31 per share, for a total transaction of $97,650.00. Following the acquisition, the chief executive officer now directly owns 11,310,355 shares in the company, valued at $3,506,210.05. This represents a 2.86 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.60% of the stock is owned by insiders.

Institutional Trading of Senseonics

A number of hedge funds have recently made changes to their positions in the stock. FMR LLC boosted its stake in Senseonics by 48,267.2% during the 3rd quarter. FMR LLC now owns 168,318 shares of the company’s stock valued at $59,000 after acquiring an additional 167,970 shares during the last quarter. GSA Capital Partners LLP bought a new position in shares of Senseonics during the third quarter worth about $117,000. Symmetry Partners LLC acquired a new position in Senseonics in the third quarter worth about $164,000. Cubist Systematic Strategies LLC increased its holdings in Senseonics by 25.9% in the second quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock valued at $166,000 after buying an additional 85,501 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in Senseonics by 3.2% during the third quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company’s stock valued at $2,042,000 after buying an additional 179,103 shares in the last quarter. Institutional investors and hedge funds own 12.36% of the company’s stock.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.